000 01455 a2200421 4500
005 20250511194617.0
264 0 _c19920810
008 199208s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00265918
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStewart, D A
245 0 0 _aTerodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1992
300 _a577-80 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aButylamines
_xadverse effects
650 0 4 _aCalcium Channel Blockers
_xadverse effects
650 0 4 _aElectrocardiography
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aParasympatholytics
_xadverse effects
650 0 4 _aProspective Studies
650 0 4 _aTachycardia
_xchemically induced
650 0 4 _aUrinary Incontinence
_xdrug therapy
700 1 _aTaylor, J
700 1 _aGhosh, S
700 1 _aMacphee, G J
700 1 _aAbdullah, I
700 1 _aMcLenachan, J M
700 1 _aStott, D J
773 0 _tEuropean journal of clinical pharmacology
_gvol. 42
_gno. 6
_gp. 577-80
856 4 0 _uhttps://doi.org/10.1007/BF00265918
_zAvailable from publisher's website
999 _c1630375
_d1630375